Showing results (111-120 of 254) with videos related to
Sort By:
Pageof 26
The Journal of Infectious Diseases|April 30, 2004
Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohortValerio Tozzi, Mauro Zaccarelli, Pasquale Narciso, et al.The Journal of Antimicrobial Chemotherapy|September 25, 2018
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ARTFrancesca Ceccherini-Silberstein, Alessandro Cozzi Lepri, Claudia Alteri, et al.Viruses|July 29, 2020
Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in ItalyLavinia Fabeni, Maria Mercedes Santoro, Patrizia Lorenzini, et al.Antiviral Therapy|October 26, 2011
Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usageValentina Svicher, Claudia Alteri, Anna Artese, et al.Gut|January 6, 2021
Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis BValentina Svicher, Romina Salpini, Lorenzo Piermatteo, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 24, 2019
Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological successClaudia Alteri, Rossana Scutari, Christof Stingone, et al.Plos One|May 19, 2017
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohortAntonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Francesca Ceccherini-Silberstein, et al.The Journal of Antimicrobial Chemotherapy|September 30, 2017
Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept studyValeria Cento, Marianna Aragri, Elisabetta Teti, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 4, 2003
Virologic correlates of adherence to antiretroviral medications and therapeutic failureCarlo Federico Perno, Francesca Ceccherini-Silberstein, Andrea De Luca, et al.The Journal of Antimicrobial Chemotherapy|September 22, 2011
The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtypeIsabelle Malet, Slim Fourati, Charlotte Charpentier, et al.Pageof 26